Skip to main content

Bladder Mucosa Graft

The bladder mucosa graft is an autologous tissue substitute harvested from the urothelium of the urinary bladder, historically used across multiple domains of urologic and urogynecologic reconstruction. It was once a prominent graft material — particularly in pediatric urethral reconstruction in the 1980s–1990s — but has been largely supplanted by buccal mucosa for most urethral applications. The AUA Urethral Stricture Disease Guideline (2023) now recommends oral mucosa as the first-choice graft for substitution urethroplasty.[1][2][3][4]

The strongest contemporary evidence base for bladder mucosa is in vesicovaginal fistula (VVF) repair, where free bladder-mucosa autograft interposition achieves consistent 91–96% success rates across multiple series.[5][6][7][8]

See the overview article for graft-selection principles: Grafts in GU Reconstruction.

Historical Context​

Bladder mucosa was among the earliest autologous graft materials used in urethral reconstruction (Memmelaar 1947 original description), and saw substantive use through the 1980s–1990s for pediatric hypospadias repair, exstrophy / epispadias, and acquired urethral stricture disease in children.[1][2][3] It was favored because urothelium is naturally adapted to a wet, urine-exposed environment.

The emergence of buccal mucosa in the 1990s — with simpler intraoral harvest, lower morbidity, and equivalent-to-superior outcomes — progressively displaced bladder mucosa as the urethral-substitute material of choice. The AUA 2023 Urethral Stricture Disease Guideline now positions oral mucosa as first-choice (Strong Recommendation, Grade A), with no specific indication for bladder mucosa in modern urethroplasty.[4]

Properties of Bladder Mucosa as a Graft​

PropertyDetail
Urothelial originNaturally tolerant of urine exposure — theoretically ideal for urinary-tract reconstruction
Angiogenic activityAnimal studies (Gardikis 2005) show angiogenic activity comparable to buccal mucosa and significantly superior to skin grafts[9]
Graft shrinkage20–40% — significantly worse than buccal mucosa (~10%); contributes to stricture recurrence[10]
Stricture rate (experimental)El-Sherbiny 2002 canine model: bladder mucosa 37% stricture rate vs buccal mucosa 12% vs skin 62%; onlay configurations significantly outperformed tubularized[10]
Harvest morbidityHigher — requires suprapubic / open cystotomy, abdominal incision, and bladder drainage — vs the simple intraoral harvest of buccal mucosa[1][9]
Donor-site healingThe urothelial donor defect on the bladder dome re-epithelializes spontaneously[7]

Clinical Applications​

1. Vesicovaginal fistula (VVF) repair — the strongest contemporary indication​

This is the application where bladder mucosa grafts have shown the most consistent and favorable contemporary results, particularly for complex, recurrent, large, or radiation-induced VVF.

SeriesnSuccessFollow-up
Brandt 1998 (15-year experience)8096.3% with no late failures15 yr
Ostad 1998 (high / large / multiple / recurrent VVF)6100% long-term dryness2–6 yr
Sharifi-Aghdas 2002 (complicated VVF)1493% (13/14 dry)—
Vyas 20052291% continence (20/22). Both failures had undergone two prior repairs each—

The technique:[7]

  1. Harvest a free mucosal graft from an unaffected portion of the bladder dome via suprapubic cystotomy
  2. Debride the fistulous tract
  3. Place the graft over the defect with stay sutures — without extensive dissection, rotational flaps, or peritoneal entry

This approach is particularly advantageous when the fistula sits near the ureteral orifices, where the graft can be tailored to the defect without requiring ureteral reimplantation — the technical edge over interposition options like the Martius flap and peritoneal flap in this anatomic subset.[6]

2. Urethral reconstruction — historical, largely supplanted​

Bladder mucosa was used extensively for complex urethral reconstruction, particularly in pediatric patients with failed hypospadias repairs and exstrophy / epispadias.

  • Kinkead 1994 (95 pts, ages 1–21) — landmark long-term follow-up: 85% overall good functional result, but 66% required additional procedures (mean 2.7) for complications. The most common complications were meatal stenosis and mucosal prolapse, especially when bladder mucosa was used as a circumferential terminal urethral segment (68% meatal problems vs 12% with onlay patch).[2]
  • Monfort 1992 — pediatric acquired strictures: 7/8 patients had good outcomes with onlay grafts.[1]
  • El-Sherbiny 2002 canine model — buccal 12% < bladder 37% < skin 62% stricture rates; onlay outperformed tubularized for all materials.[10]

The dual penalties of higher morbidity (cystotomy) and inferior outcomes (vs buccal) have ended bladder mucosa's role in adult urethroplasty.

3. Vaginoplasty for congenital anomalies​

Bladder mucosa has been used for vaginal reconstruction in congenital urogenital anomalies. Chiaramonte 2018 described tubularized bladder-mucosal-graft vaginoplasty in a child at 20 months, with follow-up to age 18 demonstrating no introital stenosis, good cosmesis, and histologic transformation to stratified squamous epithelium.[11] This approach avoids the mucus production, diversion colitis, and malignancy risk associated with intestinal-segment vaginoplasty, but is rarely used today given the dominance of penile inversion (in transgender women) and McIndoe / peritoneal / pudendal-thigh approaches.

4. Ureteral reconstruction — experimental and historical​

  • Greenberg 1983 canine model — free bladder-mucosa grafts demonstrated graft patency with preserved urothelial lining and regenerated smooth muscle.[12]
  • Yifeng 2008 — free peritoneal and bladder-mucosa grafts for ureteral mucosa avulsion in a dog model with good imaging and histology results.[13]
  • Buccal mucosa grafts have gained wider acceptance for ureteral stricture repair in contemporary practice (BMG ureteroplasty).[14]

5. Acellular bladder matrix — the tissue-engineering descendant​

Decellularized bladder matrix (BAM) is a distinct but related material derived from bladder tissue:

  • el-Kassaby 2008 RCT — acellular bladder matrix vs buccal mucosa for urethral stricture: comparable success in patients with a healthy urethral bed (89% vs 100%), but acellular bladder matrix performed poorly in patients with an unhealthy bed (33% vs 100%).[15]
  • Augmentation cystoplasty — preclinical work (Pokrywczynska 2022 large-animal model; Coutu 2014 rat MSC-seeded BAM; Pokrywczynska 2025 UROGRAFT composite) is exploring BAM as an alternative to enterocystoplasty.[16][17][18]

These remain investigational for urinary-tract reconstruction.

Bladder Mucosa vs Buccal Mucosa​

FeatureBladder mucosaBuccal mucosa
Harvest siteBladder dome (requires cystotomy)Inner cheek (simple intraoral harvest)
Harvest morbidityHigher (abdominal incision, cystotomy, bladder drainage)Lower (oral wound, transient numbness)
Graft shrinkage20–40%~10%
Stricture rate (canine model)37%12%
Urine toleranceNative urotheliumAdapts well; Lu 2010 demonstrated transdifferentiation toward urothelial phenotype over 6+ months in the bladder microenvironment[19]
Angiogenic activityHighHigh (comparable)
Fibrosis / inflammationModerateMinimal ("scarless healing")
Long-term inflammation under urineMoreLess (Filipas 1999 — buccal shows less inflammation, fibrosis, and shrinkage on prolonged urine exposure)[20]
Current AUA guideline preferenceNot recommended as first-lineFirst-line for urethroplasty (AUA 2023)

Complications and Concerns​

  • Meatal stenosis and mucosal prolapse — the most significant complication of bladder mucosa in urethral reconstruction, particularly when configured as a circumferential terminal segment (Kinkead 1994: 68% vs 12% with onlay).[2]
  • Graft contracture — 20–40% shrinkage drives stricture recurrence.[10]
  • Long-term malignancy risk — DeRosa 2015 reported penile squamous cell carcinoma 22 years after a childhood hypospadias repair with bladder mucosa graft, raising concerns about the need for long-term oncologic surveillance in patients who received bladder-mucosa urethroplasty in childhood.[21]
  • Donor-site morbidity — cystotomy adds surgical complexity, postoperative bladder drainage, and the small but real risk of bladder-related complications.

Current Role and When to Choose Bladder Mucosa​

Bladder mucosa retains a niche but legitimate role in contemporary practice:

ScenarioRationale
Complex / recurrent / radiation-induced VVF91–96% success across four series; technical advantage when fistula sits near the ureteral orifices[5][6][7][8]
Pediatric urogenital-anomaly vaginoplasty when intestinal segments are undesiredChiaramonte 2018 long-term follow-up showed durable squamous-transformation outcome[11]
Salvage urethral reconstruction when oral mucosa and skin are unavailableHistorical role; AUA 2023 still positions oral mucosa as first-line[4]

When to avoid​

  • Adult urethroplasty as first-line — buccal or lingual mucosa preferred per AUA 2023.[4]
  • Tubularized configurations — Kinkead's 68% meatal-problem rate establishes onlay as the configuration of choice for any bladder-mucosa urethral application.[2]
  • When patient cannot tolerate cystotomy — e.g., neurogenic bladder with augmented capacity, contracted bladder, or active cystitis.

Key Takeaways​

The bladder mucosa graft has been largely supplanted by buccal mucosa for urethral reconstruction in adults, owing to higher harvest morbidity (cystotomy), greater graft shrinkage (20–40% vs ~10%), and inferior stricture rates in the only direct experimental comparison (37% vs 12%, El-Sherbiny 2002).[10] The AUA 2023 guideline positions oral mucosa as first-line.[4] The strongest contemporary evidence base for bladder mucosa is in complex / recurrent / radiation-induced VVF repair, where free-graft autograft interposition achieves 91–96% success across four published series — particularly advantageous when the fistula sits near the ureteral orifices, where the graft can be tailored without requiring reimplantation.[5][6][7][8] Long-term oncologic surveillance is warranted in patients who received bladder-mucosa urethroplasty in childhood, given the DeRosa 2015 case of penile squamous cell carcinoma 22 years post-repair.[21] Acellular bladder matrix represents the active tissue-engineering descendant for urethroplasty (in healthy beds) and bladder augmentation, but remains investigational.[15][16][17][18]

See Also​

References​

1. Monfort G, Bretheau D, Di Benedetto V, Bankole R. Urethral stricture in children: treatment by urethroplasty with bladder mucosa graft. J Urol. 1992;148(5):1504–6. doi:10.1016/s0022-5347(17)36950-1

2. Kinkead TM, Borzi PA, Duffy PG, Ransley PG. Long-term followup of bladder mucosa graft for male urethral reconstruction. J Urol. 1994;151(4):1056–8. doi:10.1016/s0022-5347(17)35179-0

3. Decter RM, Roth DR, Gonzales ET. Hypospadias repair by bladder mucosal graft: an initial report. J Urol. 1988;140(5 Pt 2):1256–8. doi:10.1016/s0022-5347(17)42018-0

4. Wessells H, Morey A, Souter L, Rahimi L, Vanni A. Urethral stricture disease guideline amendment (2023). J Urol. 2023;210(1):64–71. doi:10.1097/JU.0000000000003482

5. Brandt FT, Lorenzato FR, Albuquerque CD. Treatment of vesicovaginal fistula by bladder mucosa autograft technique. J Am Coll Surg. 1998;186(6):645–8. doi:10.1016/s1072-7515(98)00129-x

6. Vyas N, Nandi PR, Mahmood M, et al. Bladder mucosal autografts for repair of vesicovaginal fistula. BJOG. 2005;112(1):112–4. doi:10.1111/j.1471-0528.2004.00316.x

7. Ostad M, Uzzo RG, Coleman J, Young GP. Use of a free bladder mucosal graft for simple repair of vesicovaginal fistulae. Urology. 1998;52(1):123–6. doi:10.1016/s0090-4295(98)00120-4

8. Sharifi-Aghdas F, Ghaderian N, Payvand A. Free bladder mucosal autograft in the treatment of complicated vesicovaginal fistula. BJU Int. 2002;89 Suppl 1:54–6. doi:10.1046/j.1464-4096.2001.01728.x

9. Gardikis S, Giatromanolaki A, Ypsilantis P, et al. Comparison of angiogenic activities after urethral reconstruction using free grafts in rabbits. Eur Urol. 2005;47(3):417–21. doi:10.1016/j.eururo.2004.10.014

10. El-Sherbiny MT, Abol-Enein H, Dawaba MS, Ghoneim MA. Treatment of urethral defects: skin, buccal or bladder mucosa, tube or patch? An experimental study in dogs. J Urol. 2002;167(5):2225–8.

11. Chiaramonte C, Vestri E, Tripi F, et al. Bladder mucosal graft vaginoplasty: a case report. J Pediatr Adolesc Gynecol. 2018;31(5):528–32. doi:10.1016/j.jpag.2018.06.003

12. Greenberg R, Coleman JW, Quiguyan CC, et al. Bladder mucosal grafts: experimental use as a ureteral substitute and observation of certain physical properties. J Urol. 1983;129(3):634–6. doi:10.1016/s0022-5347(17)52268-5

13. Yifeng J, Shujie X, Hongbin S, et al. Use of free peritoneal and bladder mucosal grafts as ureteral mucosa substitutes for management of avulsion of the ureteral mucosa in a dog model. J Endourol. 2008;22(4):729–34. doi:10.1089/end.2007.0136

14. Bello D, Van Shufflin M, Hofer MD. Expanding the armamentarium: perspectives on buccal mucosal grafts and appendiceal flaps in ureteral reconstructive surgery. J Clin Med. 2025;14(21):7681. doi:10.3390/jcm14217681

15. el-Kassaby A, AbouShwareb T, Atala A. Randomized comparative study between buccal mucosal and acellular bladder matrix grafts in complex anterior urethral strictures. J Urol. 2008;179(4):1432–6. doi:10.1016/j.juro.2007.11.101

16. Pokrywczynska M, Jundzill A, Tworkiewicz J, et al. Urinary bladder augmentation with acellular biologic scaffold — a preclinical study in a large animal model. J Biomed Mater Res B Appl Biomater. 2022;110(2):438–49. doi:10.1002/jbm.b.34920

17. Coutu DL, Mahfouz W, Loutochin O, Galipeau J, Corcos J. Tissue engineering of rat bladder using marrow-derived mesenchymal stem cells and bladder acellular matrix. PLoS One. 2014;9(12):e111966. doi:10.1371/journal.pone.0111966

18. Pokrywczynska M, Fekner Z, Balcerczyk D, et al. Development of UROGRAFT: a bladder acellular matrix-based composite for advanced cystoplasty, highlighting the role of graft shape and composition. ACS Biomater Sci Eng. 2025;published online. doi:10.1021/acsbiomaterials.5c00700

19. Lu M, Zhou G, Liu W, et al. Remodeling of buccal mucosa by bladder microenvironment. Urology. 2010;75(6):1514.e7–14. doi:10.1016/j.urology.2009.12.060

20. Filipas D, Fisch M, Fichtner J, et al. The histology and immunohistochemistry of free buccal mucosa and full-skin grafts after exposure to urine. BJU Int. 1999;84(1):108–11. doi:10.1046/j.1464-410x.1999.00079.x

21. DeRosa R, Stackhouse DA, McMann LP, Sterbis JR. Penile squamous cell carcinoma after a childhood hypospadias repair with bladder mucosa graft. Urology. 2015;85(6):1471–3. doi:10.1016/j.urology.2015.02.021